Order results by:
| Issue | Title | |
| Vol 4, No 4 (2012) | Citicoline for ischemic stroke: ICTUS trial | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... of the ICTUS trial in which 2298 patients with IS who received randomly citicoline or placebo for 24 hours ..." | ||
| Vol 7, No 3 (2015) | The heterogeneity of vascular cognitive impairments and the issues of therapy | Abstract similar documents |
| Elena Anatolyevna Katunina | ||
| "... and 48% after 25 years. The paper reviews the most important trials of citicoline used in CIs. The drug ..." | ||
| Vol 12, No 2 (2020) | The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment | Abstract similar documents |
| V. A. Golovacheva | ||
| "... indicating a cognitive defect. Citicoline is one of the most widely used nootropic drugs for cerebrovascular ..." | ||
| Vol 6, No 3 (2014) | Effect of citicoline on blood pressure variability | Abstract similar documents |
| O. D. Ostroumova, N. Yu. Taranenko | ||
| "... The authors give the results of their investigation dealing with citicoline therapy in patients ..." | ||
| Vol 13, No 1 (2021) | Cognitive impairment in COVID-19 survivors | Abstract similar documents |
| T. M. Ostroumova, P. A. Chernousov, I. V. Kuznetsov | ||
| "... and the possibility of their correction with citicoline (Noocil®). ..." | ||
| Vol 2, No 3 (2010) | Clinical experience with ceraxon used in ischemic stroke | Abstract similar documents |
| V. A. Parfenov, T. G. Fateyeva, O. V. Kosivtsova | ||
| "... Citicoline (Ceraxon) is a neuroprotective agent used in acute ischemic stroke (IS) and chronic ..." | ||
| Vol 3, No 3 (2011) | Poststroke cognitive impairments and their therapy with ceraxon | Abstract similar documents |
| N. V. Shakhparonova, A. S. Kadykov, E. M. Kashina | ||
| "... Objective: to evaluate the effect of citicoline (ceraxon) on recovery of cognitive functions ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... Objective: to investigate the efficacy and safety of citicoline (Ceresil® Canon) in patients ..." | ||
| Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
| L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... therapies for MCI. Multiple pharmacological effects of citicoline on cognitive functions of patient ..." | ||
| Vol 12, No 4 (2020) | Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, I. A. Shchukin | ||
| "... Objective: to investigate the effect of citicoline (CTC) on gene transcription. Material ..." | ||
| Vol 8, No 2 (2016) | Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina, D. O. Gromova | ||
| "... citicoline in the recovery period of IS are given. The use of citicoline is shown to cause a significant ..." | ||
| Vol 3, No 1 (2011) | Current treatments for brain contusions | Abstract similar documents |
| A. E. Talypov, S. S. Petrikov, Yu. V. Puras, A. A. Solodov, Yu. V. Titova | ||
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... of citicoline, which has a neuroprotective effect. Objective: to evaluate the effect of treatment ..." | ||
| Vol 13, No 1 (2021) | Chronic cerebral ischemia and headache in patients in primary care physician's practice | Abstract similar documents |
| V. N. Shishkova, T. V. Adasheva | ||
| "... ) and Neupilept® (citicoline) in this category of patients. ..." | ||
| Vol 16, No 1 (2024) | Treatment of cognitive impairment in patients with cerebral infarction in the internal carotid arteries circulation system: results of a multicentre, randomized, double-blind, placebo-controlled clinical trial | Abstract similar documents |
| D. R. Khasanova, A. A. Yakupova, P. R. Kamchatnov, Zh. Yu. Chefranova, E. I. Bogdanov, P. I Pilipenko, N. M. Khasanova | ||
| "... and methods. The double-blind, placebo-controlled, randomized clinical trial enrolled 246 patients aged 40 ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Motor function recovery in patients after ischemic stroke | Abstract similar documents |
| Yu. A. Starchina | ||
| "... in post-stroke movement disorders. The use of citicoline to improve motor function recovery is discussed. ..." | ||
| Vol 16, No 5 (2024) | Asthenia and vascular cognitive impairment in young patients after stroke | Abstract similar documents |
| L. A. Shchepankevich, K. V. Rerikh, M. S. Ponomareva, A. V. Zatynko, E. V. Taneeva | ||
| "... with citicoline is still controversial. Objective: to evaluate the prevalence of PSCI and PSA in young patients ..." | ||
| Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
| "... of choline alfoscerate and citicoline in CI treatment. he discussion includes ways to improve patient ..." | ||
| Vol 1, No 3-4 (2009) | CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS | Abstract similar documents |
| V. A. Parfenov | ||
| "... Citicolin (ceraxon) is used as a neuroprotector in the treatment of acute stroke and vascular ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... properties of cyticolin and its use in cognitive impairments (CIs). It assesses trials investigating ..." | ||
| Vol 9, No 1 (2017) | Comparison of the efficacy of the multimodal serotonergic antidepressants trazodone and vortioxetine in the treatment of patients with endogenous depression: A meta-analysis of double-blind randomized placebo-controlled trials | Abstract similar documents |
| D. S. Danilov | ||
| "... -blind, randomized, placebo-controlled trials of the efficiency of therapy with trazodone or vortioxetine ..." | ||
| Vol 15, No 5 (2023) | Efficacy and safety of Vespireit® (buspirone) prolonged-release tablets (PR) 15 mg in the therapy of patients with functional dizziness: results of the double-blind, placebo-controlled, multicenter, randomized, phase 3 clinical trial | Abstract similar documents |
| M. V. Zamergrad, V. A. Parfenov, A. S. Agafina, N. V. Lyamina, M. M. Gavrik, L. R. Kuchumova, E. R. Barantsevich, V. S. Krasnov, A. A. Ivanova, A. L. Vladykin, K. А. Ishchenko | ||
| "... “Valenta Pharm”, Russia) compared with placebo in the treatment of patients with autonomic dysfunction ..." | ||
| Vol 10, No 3 (2018) | Placebo analgesia | Abstract similar documents |
| G. R. Tabeeva | ||
| "... Placebos are drugs, devices, or other treatments that are physically and pharmacologically inert ..." | ||
| Vol 5, No 1 (2013) | Blood pressure lowering-based prevention and the POWER trial | Abstract similar documents |
| Vladimir Anatolyevich Parfenov, S V Verbitskaya | ||
| "... on and the results of large randomized placebo-controlled trials of different antihypertensive drugs used to prevent ..." | ||
| Vol 8, No 3 (2016) | Chemoreactome analysis of ethylmethylhydroxypyridine succinate | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov | ||
| "... acid and citicoline were used as the molecules of comparison (control molecules). Material ..." | ||
| Vol 7, No 1 (2015) | Current therapy for chronic cerebrovascular attack | Abstract similar documents |
| A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova | ||
| "... be given in a risk situation and to reduce damage. Citicoline is one of the most test drugs in a group ..." | ||
| Vol 3, No 4 (2011) | Use of L-lysine aescinate in central nervous system diseases | Abstract similar documents |
| V. A. Parfenov | ||
| "... multicenter placebo-controlled trials of the efficacy and safety of the drug in CNS diseases. ..." | ||
| Vol 5, No 2S (2013): Special issue "Stroke" | Management of patients with post-stroke dementia | Abstract similar documents |
| Svetlana Viktorovna Verbitskaya | ||
| "... the data available in the literature on the results of randomized placebo-controlled trials evaluating ..." | ||
| Vol 4, No 1 (2012) | Antyhypertensive therapy-based secondary prevention of ischemic stroke | Abstract similar documents |
| Vladimir Anatolyevich Parfenov, S V Verbitskaya, Yu A Starchina | ||
| "... by using antihypertensive therapy. It gives international guidelines and the results of randomized placebo ..." | ||
| Vol 16, No 5 (2024) | The Effect of Adding Agomelatine to Escitalopram in the Treatment of Major Depressive Disorder | Abstract PDF (Eng) similar documents |
| H. Azadi, P. Rashidpour, S. M. Yassini Ardekani, M. Nadi Sakhvidi, H. Afshang, R. Bidaki | ||
| "... randomized clinical trial with before and after designs (b and a). In this study, 70 patients with MDD ..." | ||
| Vol 8, No 2 (2016) | Effect of cerebrolysin on motor function restoration during medical rehabilitation | Abstract similar documents |
| M. A. Kustova, A. P. Tolmachev, N. A. Shamalov | ||
| "... components. The paper gives the January 2016 results of the randomized placebo-controlled multicenter study ..." | ||
| Vol 3, No 3 (2011) | Treatment for poststroke spasticity, the use of mydocalm | Abstract similar documents |
| V. A. Parfenov | ||
| "... as oral medications. The paper also presents the results of a placebo-controlled trial that has indicated ..." | ||
| Vol 13, No 1S (2021): Спецвыпуск: рассеянный склероз | Current ethical issues of clinical trials of drugs for the pathogenetic therapy of multiple sclerosis in the context of the COVID-19 pandemic | Abstract similar documents |
| E. V. Ivashkova, A. M. Petrov, M. V. Votintseva, I. D. Stolyarov | ||
| "... during a pandemic. We also analyze the ethical aspects of clinical trials, the problems faced ..." | ||
| Vol 7, No 1 (2015) | Non-biological complex drugs and their analogues in the pathogenetic therapy of multiple sclerosis: Issues of efficacy and safety in clinical use | Abstract similar documents |
| I. D. Stolyarov, A. M. Petrov, M. V. Votintseva, I. G. Nikiforova | ||
| "... . The performed analysis of clinical trials suggests the high efficacy and favorable safety profile of the drug ..." | ||
| Vol 11, No 4 (2019) | Current requirements for studies of drugs for the pathogenetic treatment of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. N. Spirin, Ya. V. Vlasov, M. N. Zakharova | ||
| "... be investigated in strict accordance with the evidence-based medicine principles governing clinical trials ..." | ||
| Vol 11, No 4 (2019) | New possibilities for the therapy of secondary progressive multiple sclerosis | Abstract similar documents |
| A. M. Petrov, E. V. Ivashkova, I. D. Stolyarov | ||
| "... sphingosine-1-phosphate types 1 and 5 receptor modulator that has been shown to be more effective than placebo ..." | ||
| Vol 17, No 1 (2025) | A new representative of the group of non-steroidal anti-inflammatory drugs in the therapeutic arsenal of a Russian doctor: pelubiprofen | Abstract similar documents |
| A. E. Karateev | ||
| "... of double-blind, randomized and controlled trials comparing it with aceclofenac and celecoxib. These studies ..." | ||
| Vol 15, No 4 (2023) | Evaluation of pharmacokinetic parameters, safety and tolerability of single and multiple doses of Vespireit®: results of phase I clinical trial. | Abstract similar documents |
| O. D. Ostroumova, M. L. Maksimov, M. V. Zamergrad, V. A. Parfenov, E. K. Zaharova, A. L. Vladykin, A. A. Globenko, A. V. Kapashin, K. A. Ishchenko | ||
| "... comparative clinical trial of Vespireit®. At stages 1 and 2, healthy volunteers were screened and randomized ..." | ||
| Vol 16, No 6 (2024) | Efficacy of cognitive behavioral therapy in chronic migraine and medication overuse headache: a prospective randomized trial | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva | ||
| "... ) and medication overuse headache (MOH), but there are few randomized trials to evaluate its efficacy. Objective ..." | ||
| Vol 16, No 1S (2024): Спецвыпуск: Головная боль | Comparative analysis of the efficacy of different treatment strategies in medication overuse headache: an open-label prospective trial | Abstract similar documents |
| A. V. Sergeev, E. A. Guziy, N. A. Kovalchuk, E. A. Sokolov, G. V. Grigoriev, G. R. Tabeeva | ||
| Vol 7, No 1 (2015) | Clinical experience with L-lysine escinate for acute and chronic cerebral circulatory disorders | Abstract similar documents |
| N. V. Pizova | ||
| "... in uncontrolled and small placebo-controlled trials, are widely used in our country. The prescription ..." | ||
| Vol 4, No 1 (2012) | Sustained-release pramipexole in the treatment of Parkinson’s disease | Abstract similar documents |
| Natalia Vladimirovna Fedorova | ||
| "... and extensive PD stages; its clinical efficacy has been proven in many double-blind randomized placebo ..." | ||
| Vol 14, No 4 (2022) | Pharmacotherapy of pain in musculoskeletal diseases: evolution and revolution of views | Abstract similar documents |
| O. A. Shavlovskaya, I. V. Sarvilina, O. A. Gromova, M. N. Sharov, I. A. Bokova, Y. S. Prokofieva, N. I. Shavlovskiy | ||
| "... , which is reflected in a meta-analysis (2019), a randomized placebo-controlled trial (2019), approved ..." | ||
| Vol 9, No 1 (2017) | Evaluation of the safety and efficacy of the Russian botulinum toxin-A relatox versus botox in treating arm and hand spasticity after ischemic stroke: A multicenter randomized trial | Abstract similar documents |
| S. E. Khatkova, E. V. Kostenko, D. V. Pokhabov, A. V. Gustov, A. N. Kalyagin, N. G. Zhukova | ||
| "... . A multicenter randomized clinical trial was conducted in 6 centers of the Russian Federation, which covered 160 ..." | ||
| Vol 17, No 3 (2025) | Mild cognitive impairment due to cerebrovascular disease and Alzheimer’s | Abstract similar documents |
| V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Grinyuk, V. V. Zakharov, K. V. Shevtsova | ||
| "... with MCI due to AD. The results of multicenter placebo-controlled trials of the drug Prospekta in vascular ..." | ||
| Vol 11, No 4 (2019) | Target determination for transcranial magnetic stimulation in patients with a pharmacotherapy-resistant depressive episode based on the individual parameters of resting-state functional magnetic resonance imaging (a pilot blind controlled trial) | Abstract similar documents |
| A. G. Poydasheva, D. O. Sinitsyn, I. S. Bakulin, N. A. Suponeva, N. V. Maslennikov, E. E. Tsukarzi, S. N. Mosolov, M. A. Piradov | ||
| Vol 8, No 1 (2016) | The rationale for antidepressants in the treatment of schizophrenia: A modern view on the problem in the context of evidence-based medicine | Abstract similar documents |
| D. S. Danilov, D. O. Magomedova, M. E. Matsneva | ||
| "... the results from trials evaluating the efficiency of the therapy in patients with depressive, negative ..." | ||
| Vol 12, No 3 (2020) | Memantine: procognitive and antinegative effects in mental illness (a literature review) | Abstract similar documents |
| D. V. Romanov, P. G. Yuzbashyan | ||
| "... , placebo-controlled studies. ..." | ||
| Vol 14, No 5 (2022) | Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups | Abstract similar documents |
| E. A. Ushkalova, S. K. Zyryanov, O. I. Butranova | ||
| "... multiple pharmacological effects. In order to study the safety of Mexidol in comparison with placebo ..." | ||
| Vol 16, No 6 (2024) | Biofeedback neurotraining in the correction of emotional changes in early cerebral small vessel disease | Abstract similar documents |
| E. S. Novikova, L. A. Dobrynina, O. R. Dobrushina, M. A. Afanasev, A. V. Volik, E. V. Gnedovskaya, G. A. Arina, V. V. Aristova, D. A. Kazantseva | ||
| "... into three groups using the envelope method with double-blind placebo control: BF-neurotraining at infra-low ..." | ||
| Vol 4, No 1 (2012) | Post-stroke depression: scientifically substantiated approaches to choosing therapy | Abstract similar documents |
| Yulia Aleksandrovna Starchina | ||
| "... the clinical types of PSD, the results of trials of the efficacy of antidepressants in these patients ..." | ||
| Vol 14, No 6 (2022) | Treatment of acute non-specific back pain, the use of group B vitamins | Abstract similar documents |
| V. A. Parfenov | ||
| "... back pain is discussed, data from placebo-controlled studies and a meta-analysis of studies on the use ..." | ||
| Vol 12, No 2 (2020) | Etoricoxib can be used for chronic nonspecific back pain: a new indication of the well-known drug | Abstract similar documents |
| A. E. Karateev | ||
| "... is significantly superior to placebo and that at a dose of 150 mg/day is not inferior to diclofenac. The important ..." | ||
| Vol 7, No 3 (2015) | Experience in using levodopa-benserazide | Abstract similar documents |
| Elena Anatolyevna Katunina, Yu. N. Bezdolnyi, E. A. Malykhina, N. V. Titova | ||
| "... of comparative trials of levodopa-benserazide and levodopa-carbidopa and the clinical experience with Levodopa ..." | ||
| Vol 10, No 3 (2018) | The level of interleukin-6 in acute ischemic stroke: effect on the rate of recovery in patients and on the severity of neurological defect | Abstract similar documents |
| S. P. Sergeeva, А. А. Savin, I. D. Breslavich, P. F. Litvitsky, V. V. Arkhipov | ||
| "... subtype II was established in accordance with the TOAST (Trial of Org 10172 in Acute Stroke Treatment ..." | ||
| Vol 13, No 6 (2021) | Multicenter, randomized, double-blind study of the efficacy and safety of prolonged release tolperisone hydrochloride 450 mg (Mydocalm® Long, once daily) and tolperisone hydrochloride 150 mg (three times daily) for acute non-specific lower back pain | Abstract similar documents |
| V. A. Parfenov, E. I. Bogdanov, V. B. Laskov, N. S. Makarov, N. V. Pisova, E. A. Salina, Zh. Yu. Chefranova, L. V. Chichanovskaya | ||
| "... included in the study. The two placebo method was used to mask the prescribed treatment. Inpatients ..." | ||
| Vol 9, No 3 (2017) | Possibilities of therapy for early manifestations of chronic cerebral ischemia: results of the PROFILE program | Abstract similar documents |
| G. R. Tabeeva, E. Yu. Kalimeeva, N. N. Koberskaya, S. I. Gereeva | ||
| "... , it is advisable to conduct a comparative placebo-controlled investigation. ..." | ||
| Vol 6, No 1 (2014) | The use of neurocytoprotectors to improve rehabilitation of patients after cerebrovascular accident | Abstract similar documents |
| V.V. Kovalchuk | ||
| "... state of patients after a stroke. Further randomized, placebo-controlled studies of Thiocetam efficacy ..." | ||
| Vol 16, No 6 (2024) | Management of patients with cognitive impairment in old age | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Sokolov | ||
| "... placebo-controlled ASCOMALVA study are discussed, in which the addition of choline alfoscerate ..." | ||
| Vol 16, No 4 (2024) | Aviandr is a new original drug for treating anxiety | Abstract similar documents |
| V. A. Parfenov | ||
| "... was investigated in patients with generalized AD (GAD) in a double-blind, placebo-controlled, randomized study ..." | ||
| Vol 12, No 4 (2020) | Tolperisone in the treatment of acute and chronic nonspecific back pain | Abstract similar documents |
| V. A. Golovacheva, A. A. Golovacheva, O. E. Zinovyeva, V. L. Golubev | ||
| "... and in the countries of Europe and Asia. Clinical trials have shown the efficacy and good tolerance of tolperisone used ..." | ||
| Vol 12, No 5 (2020) | NMDA receptor antagonists in the treatment of neurological diseases | Abstract similar documents |
| I. S. Preobrazhenskaya | ||
| "... The paper reviews clinical trials evaluating the efficacy of N-methyl-D-aspartate (NMDA) receptor ..." | ||
| Vol 10, No 4 (2018) | Serotonin and norepinephrine reuptake inhibitor antidepressants: a look through the prism of their 30-year history | Abstract similar documents |
| D. S. Danilov | ||
| "... of the efficiency of depression therapy with drugs of this group in clinical trials and post-marketing studies ..." | ||
| Vol 12, No 4 (2020) | Diabetic polyneuropathy: diagnosis, prevention, and treatment | Abstract similar documents |
| V. A. Golovacheva, I. A. Strokov | ||
| "... treatment of DSSMPN and describes the results of clinical trials of its treatment with ALA preparations. ..." | ||
| Vol 10, No 1 (2018) | New drugs for anti-B-cell therapy of multiple sclerosis | Abstract similar documents |
| A. N. Boyko, N. Yu. Lashch, M. E. Guseva | ||
| "... for multiple sclerosis (MS) and the results of clinical trials of ocrelizumab, the first drug of this group ..." | ||
| Vol 9, No 1 (2017) | Combination therapy for cognitive and emotional impairments in patients with arterial hypertension | Abstract similar documents |
| O. D. Ostroumova, E. A. Karavashkina | ||
| "... ®) and the results of its trials are discussed. The paper describes a clinical case illustrating the efficacy ..." | ||
| Vol 8, No 3 (2016) | Systematic analysis of basic and clinical studies of etifoxine | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, V. A. Semenov, T. R. Grishina | ||
| "... . The results of clinical trials of etifoxine are also analyzed. In addition to its anxiolytic effect ..." | ||
| Vol 9, No 2 (2017) | Chronic cerebral ischemia, neuroplasticity, possibilities of therapy | Abstract similar documents |
| E. I. Chukanova, A. S. Chukanova | ||
| "... of the neuropeptide drug Cerebrolysin are reviewed. The authors describe in detail the results of the clinical trial ..." | ||
| Vol 1, No 3-4 (2009) | DIAGNOSTICS AND TREATMENT OF LOW BACK PAIN | Abstract similar documents |
| R. A. Altunbaev, M. Z. Sabirova | ||
| "... , and other agents. The data of clinical trials of meloxicam used in LBP are presented. The currently ..." | ||
| Vol 4, No 1 (2012) | Lewy body dementia: clinical manifestations, diagnosis, and treatment | Abstract similar documents |
| Irina Sergeyevna Preobrazhenskaya | ||
| "... with basic symptomatic therapy are given. The results of the clinical trial of the activity of akatinol ..." | ||
| 1 - 70 of 147 Items | 1 2 3 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
